Clinical utility of serum beta-2-microglobulin as a predictor of diabetic complications in patients with type 2 diabetes without renal impairment

Diabetes and Metabolism

Volumn 40, Issue 6, 2014, Pages 459-465

  Kim, M K ^a   Yun, K J ^a   Chun, H J ^a   Jang, E H ^a   Han, K D ^b   Park, Y M ^c   Baek, K H ^a   Song, K H ^a   Cha, B Y ^a   Park, C S ^a   Kwon, H S ^a  

^a The Catholic University of Korea   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Atherosclerosis; Beta 2 microglobulin; Complications; Type 2 diabetes mellitus

Indexed keywords

BETA 2 MICROGLOBULIN; CREATININE; HOMOCYSTEINE;

ADULT; ALBUMINURIA; ALCOHOL CONSUMPTION; AREA UNDER THE CURVE; ARTERIAL STIFFNESS; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BODY MASS; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIABETIC NEPHROPATHY; DIABETIC PATIENT; DIABETIC RETINOPATHY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE DURATION; FEMALE; GENDER; HUMAN; HYPERTENSION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PULSE WAVE; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SMOKING; SUBCLINICAL ATHEROSCLEROSIS; URINE ALBUMIN TO CREATININE RATIO; UROGENITAL SYSTEM PARAMETERS;

EID: 84919488305     PISSN: 12623636     EISSN: 18781780     Source Type: Journal    
DOI: 10.1016/j.diabet.2014.08.002     Document Type: Article

References (15)

1. Amighi J., Hoke M., Mlekusch W., Schlager O., Exner M., Haumer M., et al. Beta 2 microglobulin and the risk for cardiovascular events in patients with asymptomatic carotid atherosclerosis. Stroke 2011, 42:1826-1833.
2. Liabeuf S., Lenglet A., Desjardins L., Neirynck N., Glorieux G., Lemke H.D., et al. Plasma beta-2 microglobulin is associated with cardiovascular disease in uremic patients. Kidney Int 2012, 82:1297-1303.
3. Shinkai S., Chaves P.H., Fujiwara Y., Watanabe S., Shibata H., Yoshida H., et al. Beta2-microglobulin for risk stratification of total mortality in the elderly population: comparison with cystatin C and C-reactive protein. Arch Intern Med 2008, 168:200-206.
4. Foster M.C., Inker L.A., Levey A.S., Selvin E., Eckfeldt J., Juraschek S.P., et al. Novel filtration markers as predictors of all-cause and cardiovascular mortality in US adults. Am J Kidney Dis 2013, 62:42-51.
5. Cheung CL1, Lam K.S., Cheung B.M. Serum β-2 microglobulin predicts mortality in people with diabetes. Eur J Endocrinol 2013, 169:1-7.
6. Mancia G., De Backer G., Dominiczak A., Cifkova R., Fagard R., et al. Guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2007, 28:1462-1536.
7. Pencina M.J., D'Agostino R.B., D'Agostino R.B., Vasan R.S. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008, 27:157-172.
8. Kong F.L., Cheng W., Chen J., Liang Y. d-Ribose glycates β(2)-microglobulin to form aggregates with high cytotoxicity through a ROS-mediated pathway. Chem Biol Interact 2011, 194:69-78.
9. Wilson A.M., Kimura E., Harada R.K., Nair N., Narasimhan B., Meng X.Y., et al. Beta2-microglobulin as a biomarker in peripheral arterial disease: proteomic profiling and clinical studies. Circulation 2007, 116:1396-1403.
10. Stanga Z.L., Nock S., Medina-Escobar P., Nydegger U.E., Risch M., Risch L. Factors other than the glomerular filtration rate that determine the serum beta-2-microglobulin level. PLoS One 2013, 8:e72073.
11. Zumrutdal A., Sezer S., Demircan S., Seydaoglu G., Ozdemir F.N., Haberal M. Cardiac troponin I and beta 2 microglobulin as risk factors for early-onset atherosclerosis in patients on haemodialysis. Nephrology (Carlton) 2005, 10:453-458.
12. Stehouwer CD1, Smulders Y.M. Microalbuminuria and risk for cardiovascular disease: analysis of potential mechanisms. J Am Soc Nephrol 2006, 17:2106-2111.
13. Jung C.H., Baek A.R., Kim K.J., Kim B.Y., Kim C.H., Kang S.K., et al. Association between cardiac autonomic neuropathy, diabetic retinopathy and carotid atherosclerosis in patients with type 2 diabetes. Endocrinol Metab (Seoul) 2013, 28:309-319.
14. Son J.W., Jang E.H., Kim M.K., Kim H.L., Baek K.H., Song K.H., et al. Usefulness of albuminuria as predictor for coronary artery stenosis, regardless of estimated glomerular filtration rate, in patients with type 2 diabetes mellitus. Am J Cardiol 2012, 110:1434-1439.
15. Saijo Y1, Utsugi M., Yoshioka E., Horikawa N., Sato T., Gong Y., et al. Relationship of beta2-microglobulin to arterial stiffness in Japanese subjects. Hypertens Res 2005, 28:505-511.